Endo International Sees Q1 Adj. EPS $0.40-$0.50 vs $0.53 Est., Sales $620M-$680M vs $673.86M Est., Sees FY21 Adj. EPS $1.80-$2.30 vs $2.32 Est., Sales $2.55B-$2.79B vs $2.76B Est.